Neurodegenerative Research

Home ProductsAKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF740 conjugate, 0.1mg/mL

GTR00947042

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2784), CF740 conjugate, 0.1mg/mL

antibody-cd22-protein

Neurodegenerative Research

We provide research products and technical resources for neurodegenerative disease studies, neuroscience workflows, biomarker research, neuroinflammation, antibodies, ELISA kits, recombinant proteins, cell culture models, and therapeutic discovery.

[email protected]

© 2026 Neurodegenerative Research. All rights reserved.